治疗方式有利于在分化良好的神经内分泌瘤中的结果G3
Martina Hinterleitner1,2,3, Ruben Pfeiffer1, Nils F Trautwein2,4
1Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.
Frontiers in endocrinology
|January 23, 2024
概括
转移性神经内分泌瘤 (NET) G3的治疗,包括手术和受体放射性核酸治疗 (PRRT),提供生存益处. 较不激进的疗法可能适合高度增殖的NET G3.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 核医学就是核医学.
背景情况:
- 神经内分泌瘤 (NEN) 是一种罕见且多样化的瘤.
- 神经内分泌瘤 (NET) G3代表了一个小的,鲜为人知的子组.
- 关于NET G3治疗和结果的数据有限,特别是在转移阶段.
研究的目的:
- 分析NET G3患者的临床结果.
- 评估NET G3的各种诊断和治疗策略的有效性.
- 确定转移性NET G3的最佳管理方法.
主要方法:
- 现实生活中对NET G3患者的队列分析.
- 评估各种治疗方法,包括手术,辐射,体静止素类似物 (SSA) 和受体放射性核酸治疗 (PRRT).
- 评估诊断工具,如体静止素受体 (SSTR) PET-CT,FDG PET-CT和活检.
主要成果:
- 转移性NET G3患者显示了手术,放射,SSA和PRRT的生存益处.
- 所有评估的疗程都优于NET G3的经典化疗.
- SSTR PET-CT,FDG PET-CT和活检对于诊断和预后非常有用.
结论:
- 即使是转移的NET G3患者也可以从手术和PRRT等干预措施中受益.
- 通常用于低增殖性NEN的不太激进的治疗方法,可能对高增殖性NET G3有效.
- 该研究强调,需要根据预后因素为NET G3量身定制的治疗策略.
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K